ARK Invest, known for its innovative investment strategies, is exploring a groundbreaking approach to healthcare using multiomics, artificial intelligence, and big data. This convergence has the potential to revolutionize disease diagnosis and treatment, including the possibility of diagnosing cancer at or before stage 1 and reversing or curing various diseases.